By completing the tokenization of the fund, UBS enables investors to access investment strategies without the sophistication of traditional financial products.By completing the tokenization of the fund, UBS enables investors to access investment strategies without the sophistication of traditional financial products.

UBS Completes First Tokenized Fund Transaction Using Chainlink’s DTA Technical Standard

For feedback or concerns regarding this content, please contact us at [email protected]
chainlink1 19

UBS Singapore, a regional division of the international Swiss bank UBS Group, has completed the tokenization of its investment fund workflow using Chainlink’s digital transfer agent (DTA) technical standard. This means that the UBS’s Money Market Investment Fund Token (uMINT), a money market investment developed on the Ethereum blockchain, is now live and can execute transactions on-chain.

What This Partnership Means

UBS launched the Singapore-based tokenized investment fund on the Ethereum blockchain last year November 1st, 2024. The tokenized money market fund provides premier money market products, enabling investors to access yield-bearing collateral, with the ability to withdraw cash instantly. By capitalizing on Chainlink’s DTA infrastructure, UBS’s tokenized fund products are now priced with the best world-class, reliable data inputs sourced across all blockchains operating on-chain.

Chainlink’s DTA technology solution ensures resilient market data on UBS’ tokenized money market fund and offers diverse price feeds for various financial products on the investment vehicle. These Chainlink data feeds log all the fund’s financial and institutional action events like rewards, providing thorough assessments directly on-chain.

The successful integration means that Chainlink’s DTA infrastructure now automates everything from fund issuance, cash withdrawal, to data synchronization across all off-chain/on-chain systems using smart contracts, providing higher transparency and efficiency.

DigiFT, which functions as the on-chain fund distributor, leverages Chainlink’s DTA standard to process customer signups (registrations) and withdrawal requests.

Banks: Advancing RWA Tokenization

The partnership between Chainlink and UBS highlights banks’ continued adoption of RWA tokenization to link traditional investment systems with blockchain, spearheading the development of cutting-edge financial products like tokenized equities, real estate, and many more. This integration improves market liquidity, decreases transaction costs, and widens access to asset classes traditionally reserved for institutional investors and High-net-worth (HNW) individuals.

Last week, on October 29, 2025, Japan’s major securities firms and trust banks, led by SBI Holdings, announced plans to launch 24/7 tokenized stock trading, a move that is set to allow Japanese institutional and retail investors to trade tokenized versions of publicly traded stocks 24/7 with a little as 1 Japanese Yen (JPY).

Three months ago, on July 23, Bank of Goldman Sachs and New York Mellon launched Money Market Funds (MMFs) on blockchain to improve the usability and transferability of existing MMF shares. Such developments set the foundation for a more inclusive, effective financial system, cementing blockchain’s role as a game-changer in international finance.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09